| abstract |
The present invention describes novel C17-alkanediyl and alkenodiyl oleanolic acid derivatives, including those of the formula (1), wherein the variables are as defined herein. Pharmaceutical compositions, equipment and articles of manufacture comprising said compounds are also provided. Useful methods and intermediates are also provided for making the compounds, and the methods for treating the compounds, for example, as antioxidant inflammation modulators and compositions thereof. |